TSRA 31.74 Tessera Technologies $TSRA Hit a 52 week high of

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
TSRA 31.74 Tessera Technologies $TSRA Hit a 52 week high of 31.87 Currently at 31.74 +0.05 +0.16% With a day low of 31.67 and a total volume of 40,148.

TSRA Tessera Technologies Recent Headline News

Axcelis Technologies (ACLS) Jumps: Stock Rises 7.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 8:04AM CST
Axcelis Technologies Inc. (ACLS) was a big mover last session, as the company saw its shares rise over 7% on the day.
TSRA: 31.91 (+0.22), RTEC: 9.13 (-0.07), MTSN: 2.66 (+0.08), ACLS: 2.15 (unch)

Tessera Technologies Beats on Q3 Earnings & Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 2:00PM CST
Tessera Technologies Inc. (TSRA) reported strong third-quarter 2014 earnings from continuing operations that jumped from a significant loss in the year-ago quarter and small profit in the previous quarter to sail past the Zacks Consensus Estimate.
AXTI: 2.41 (+0.05), CHTR: 146.23 (-0.39), TSRA: 31.91 (+0.22), SIMO: 22.44 (-0.87)

Tessera Technologies (TSRA) Upgraded From Hold to Buy
at The Street - Mon Nov 03, 8:55AM CST
Tessera Technologies (TSRA) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B+.
TSRA: 31.91 (+0.22)

Tessera posts 3Q profit
Automated Insights - Fri Oct 31, 4:04AM CDT
SAN JOSE, Calif. (AP) _ Tessera Technologies Inc. (TSRA) on Friday reported net income of $108.7 million in its third quarter.
TSRA: 31.91 (+0.22)

Tessera Technologies' (TSRA) CEO Tom Lacey on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 9:45PM CDT

TSRA: 31.91 (+0.22)

TESSERA TECHNOLOGIES
at Investor's Business Daily - Thu Oct 30, 6:13PM CDT
TESSERA TECHNOLOGIES (TSRA), a tech firm, said Q3 EPS grew to 87 cents from last year's Q3 per-share loss of 91 cents, topping by 7 cents. Sales surged 150.4% to $93.3 mil, topping views for $91.9 mil. Shares rose.
TSRA: 31.91 (+0.22)

Tessera guides above consensus
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 5:41PM CDT

TSRA: 31.91 (+0.22)

Tessera Technologies (TSRA) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 30, 3:55PM CDT

TSRA: 31.91 (+0.22)

Tessera beats by $0.07, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 3:20PM CDT

TSRA: 31.91 (+0.22)

Tessera Technologies Announces Third Quarter 2014 Results
Business Wire - Thu Oct 30, 3:07PM CDT
--Recurring Revenue Increases 70% to $47.3 Million Year-Over-Year--
TSRA: 31.91 (+0.22)

Can Tessera Technologies' (TSRA) Earnings Surprise in Q3? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 4:40PM CDT
Tessera Technologies Inc. (TSRA) is slated to report third-quarter 2014 results on Oct 30.
AMKR: 6.51 (+0.16), TEL: 61.56 (+0.06), TSRA: 31.91 (+0.22), MELI: 134.75 (-1.79)

EMCORE Slumps: EMKR Falls 7.9% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 7:38AM CDT
EMCORE (EMKR) fell nearly 9% in the last trading session amid huge volumes, continuing its recent trend, as the stock is down over 13% in the past one-month time frame.
EMKR: 5.26 (+0.08), COHU: 11.64 (+0.15), TSRA: 31.91 (+0.22), ACLS: 2.15 (unch)

Tessera Technologies to Report Third Quarter 2014 Results on Thursday, October 30
Business Wire - Tue Oct 14, 6:00AM CDT
Tessera Technologies, Inc. (NASDAQ:TSRA) ("Tessera" or the "Company" will announce its financial results for the third quarter ended September 30, 2014 on Thursday, October 30, 2014, following the close of the market. The Company will host an earnings conference call at 5:00 p.m. Eastern (2:00 p.m. Pacific) that same day. During the call, senior management will review the Company's third quarter financial results and business outlook.
TSRA: 31.91 (+0.22)

Amkor Technology Announces Rulings in Tessera Proceedings
Business Wire - Mon Oct 13, 10:59AM CDT
Amkor Technology, Inc. (NASDAQ: AMKR) today announced two rulings in its long-running dispute with Tessera Technologies, Inc. related to a license agreement entered into in 1996 between Tessera and Amkor's predecessor. On October 10, 2014, the Patent Trial and Appeal Board at the United States Patent and Trademark Office, in an inter partes review proceeding, or IPR, ruled on our petition seeking cancellation of certain claims of U.S. Patent No. 6,046,076. In a two-one decision, the IPR board reversed its preliminary determination and denied Amkor's petition with respect to the most material claims. As previously reported, an arbitration panel has awarded Tessera royalties of $113 million plus interest, most of which relate to our alleged use of the '076 patent. The Superior Court for San Francisco County formally confirmed the arbitration panel's award on October 9.
AMKR: 6.51 (+0.16), TSRA: 31.91 (+0.22)

Amkor announces two rulings in dispute proceedings with Tessera
M2 - Mon Oct 13, 8:45AM CDT
A provider of outsourced semiconductor packaging and test services, Amkor Technology Inc (NASDAQ:AMKR) today declared two rulings in its dispute with Tessera Technologies Inc, regarding a license agreement signed in 1996 between Tessera and Amkor's predecessor.
AMKR: 6.51 (+0.16), TSRA: 31.91 (+0.22)

$128.3 Million Judgment Entered by California Court on Tessera's Arbitration Award Against Amkor
Business Wire - Fri Oct 10, 3:05PM CDT
Tessera Technologies, Inc. (NASDAQ: TSRA) ("Tessera" or the "Company" announced today that a California state court confirmed Tessera, Inc.'s arbitration award and entered judgment of $128,335,504 plus post-judgment interest against Amkor Technology, Inc. ("Amkor", and that the U.S. Patent Office confirmed the patentability of key claims in a Tessera patent that Amkor had challenged in an inter partes review ("IPR" proceeding. The patent was one of several at issue in the arbitration.
AMKR: 6.51 (+0.16), TSRA: 31.91 (+0.22)

First Week of TSRA November 22nd Options Trading
DividendChannel.com - Wed Oct 08, 9:52AM CDT
Investors in Tessera Technologies Inc saw new options begin trading this week, for the November 22nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the TSRA options chain for the new November 22nd contracts and...
TSRA: 31.91 (+0.22)

MKS Instruments Poised for Solid Growth, Risks Prevail - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 03, 10:30AM CDT
On Sep 30, 2014, we issued an updated research report on MKS Instruments, Inc. (MKSI). This electric machinery maker primarily serves the semiconductor capital equipment manufacturers.
BRKS: 11.77 (-0.13), TSRA: 31.91 (+0.22), MKSI: 36.68 (-0.12), UTEK: 19.42 (-0.17)

Tessera Technologies (TSRA) Downgraded From Buy to Hold
at The Street - Tue Sep 30, 8:13AM CDT
Tessera Technologies (TSRA) has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C.
TSRA: 31.91 (+0.22)

Aixtron SE (AIXG) Jumps: Stock Rises 9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Sep 29, 8:04AM CDT
Aixtron SE (AIXG) was a big mover last session, as the company saw its shares rise almost 9% on the day.
EMKR: 5.26 (+0.08), AIXG: 11.52 (-0.16), BRKS: 11.77 (-0.13), TSRA: 31.91 (+0.22)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 178

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 10

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 204

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 197

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 176

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 184

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 0

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 138

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 134

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 143

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Runway Growth Acquires SWK Holdings in Major Merger Deal

Updated Category News Views 292

Runway Growth Announces Acquisition of SWK Holdings Runway Growth Finance Corp. (NASDAQ: RWAY) has made a significant move by announcing its acquisition of SWK Holdings Corporation (NASDAQ: SWKH). This strategic deal, valued at around $220 million, reflects Runway's ambition to enhance its investment portfolio. Details of the Acquisition Deal The acquisition will be...

Continue Reading
Generative AI Market for Software and Coding Set for Growth

Updated Category News Views 149

Overview of the Generative AI Market The Generative AI in Software and Coding market is on a promising trajectory, with projections indicating a remarkable increase from USD 31.6 million by 2024 to USD 243.7 million by 2033, a CAGR of 25.5%. This growth reflects the rise of AI technologies capable of automating code generation and software development, streamlining...

Continue Reading
Explore NebulaGraph Cloud: Affordable Beta Access Awaits

Updated Category News Views 77

NebulaGraph Cloud Beta Preview on AWS Global We’re launching the beta preview of NebulaGraph Cloud on AWS Global, and you can try it for up to $1 for a full month. Starting now through the end of November, you can explore a highly scalable, high?performance graph database without a big upfront commitment. Spin it up, kick the tires, and see how it fits your workload....

Continue Reading
Exploring Gold's Surge: Implications for GoldHaven Resources

Updated Category News Views 198

Gold Prices Rise Amid Economic Turmoil Gold prices have experienced a remarkable rise, surging over 25% since the start of the year and stabilizing near the $4,000 per ounce mark. This increase is driven by a wave of investors looking for safe-haven assets amidst persistent inflation and economic uncertainty. Central banks have noticeably been boosting their gold...

Continue Reading
Illinois Tool Works Adjusts Earnings Outlook Amid Observer Changes

Updated Category News Views 237

Illinois Tool Works Inc. Announcements Following Q3 Results Illinois Tool Works Inc. (NYSE: ITW) recently released its third-quarter results for fiscal 2025, showcasing a mix of performance metrics that caught the interest of analysts and investors alike. The company reported a revenue increase of 2.3% year-over-year, amounting to $4.06 billion. However, this result fell...

Continue Reading